Allarity Therapeutics, Inc. - Common stock (NQ:ALLR)

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR

September 30, 2024

From The Rosen Law Firm PA

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

September 29, 2024

From Bronstein, Gewirtz & Grossman, LLC

Shareholder Rights Law Firm Robbins LLP Encourages Allarity Therapeutics, Inc. Stockholders with Large Losses to Contact the Firm for Information About the ALLR Securities Class Action

Looking Into Allarity Therapeutics's Recent Short Interest ↗

September 16, 2024

Via Benzinga

September 27, 2024

From Robbins LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Agenus, and New Fortress and Encourages Investors to Contact the Firm

September 26, 2024

ALLR CLASS ACTION REMINDER - Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Allarity Therapeutics, Inc. Securities Class Action

September 24, 2024

From Robbins LLP

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR)

September 23, 2024

From Glancy Prongay & Murray LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sage, Outset Medical, Allarity, and Super Micro and Encourages Investors to Contact the Firm

September 22, 2024

ALLR Lawsuit Reminder - Robbins LLP Reminds Stockholders of the Allarity Therapeutics, Inc. Class Action Lawsuit

September 20, 2024

From Robbins LLP

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

September 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

ROSEN, A LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR

September 20, 2024

From The Rosen Law Firm PA

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR)

September 20, 2024

From Law Offices of Howard G. Smith

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors

September 19, 2024

From Glancy Prongay & Murray LLP

Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket ↗

September 19, 2024

Via Benzinga

ALLARITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm

September 17, 2024

Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

September 17, 2024

From Rosen Law Firm

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors

September 17, 2024

From The Law Offices of Frank R. Cruz

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

September 17, 2024

Via Benzinga

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc.

September 16, 2024

From Robbins LLP

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors

September 16, 2024

From Law Offices of Howard G. Smith

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

September 16, 2024

From The Schall Law Firm

Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial

September 16, 2024

From Allarity Therapeutics, Inc.

Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 13, 2024

From Allarity Therapeutics, Inc.

Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)

September 11, 2024

From Allarity Therapeutics, Inc.

ALLARITY THERAPEUTICS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Allarity Therapeutics, Inc. (NASDAQ: ALLR), You Are to Contact The Rosen Law Firm About Your Rights

August 20, 2024

From The Rosen Law Firm PA

ALLR stock results show that Allarity Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

ALLR Stock Earnings: Allarity Therapeutics Beats EPS for Q2 2024 ↗

August 06, 2024

Via InvestorPlace

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 05, 2024

From Bronstein, Gewirtz & Grossman, LLC

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors

July 30, 2024

From Glancy Prongay & Murray LLP

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors

July 30, 2024

From Law Offices of Howard G. Smith